Health experts warn people vaccinated for rabies after animal bites since November 2023 to consult doctors due ...
The gray-market drugs flooding Silicon Valley reveal a community that believes it can move faster than the F.D.A.
This France-centric book from a former editor of the French daily Le Monde has the sense of preaching to the choir ...
Nimesulide, a non-steroidal anti-inflammatory drug (NSAID), has long been under scrutiny globally for potential liver ...
Many items on Costco shelves are just about a sure bet when it comes to customer satisfaction, but this product sold at the ...
Is FDA’s Fast Subcutaneous Lunsumio VELO Approval Reshaping the Investment Case For Roche (SWX:ROG)?
In December 2025, Genentech, part of the Roche Group, received U.S. FDA accelerated approval for Lunsumio VELO, a subcutaneous formulation of mosunetuzumab for adults with relapsed or refractory ...
Merck (MRK) looks undervalued amid 2028 Keytruda patent fears—strong Q3 results, pipeline wins, and 12x P/E suggest upside.
The Print on MSN
The curious case of the fake Abhayrab rabies vaccine
Fears mount as authorities worldwide warn travellers who received the Abhayrab rabies vaccine in India to get replacement ...
The rapid spread of that sticky serum tells you just how wildly successful K-beauty has become. Fuelled by viral content and ...
Tirzepatide can cost $500 to $1,900 a month without insurance. More affordable tirzepatide alternatives include semaglutide, ...
“Cleaning overload is a very dangerous (and ineffective) trend where a rainbow of different cleaning products are used to try ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results